Author Archives : Editorial Team

Home  >>  Author : Editorial Team

DKFZ: Blood test indicates risk of developing Alzheimer’s disease

On April 9, 2018, Posted by , In Research Article, By ,, , With Comments Off on DKFZ: Blood test indicates risk of developing Alzheimer’s disease

A newly developed blood test may indicate Alzheimer’s disease on average eight years before the clinical diagnosis. This was demonstrated by scientists from the Ruhr University Bochum (RUB), the German Cancer Research Center (DKFZ) and the Saarland Cancer Registry with a large population-based cohort study from the Saarland. Pathological deposits…

New member: Welcome to PEKKIP Oncology Alliance in our cluster

On April 4, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PEKKIP Oncology Alliance in our cluster

We are happy to welcome in our cluster PEKKIP Oncology Alliance.   “Fighting cancer needs genius and expertise – but prior to all it needs cooperation.” Ahmet Sami Pekkip – CEO PEKKIP Oncology Alliance have an excellent network of internationally renowned key opinion leaders at hand. They use this pool…

Remote Learning: new Master in Biotechnology (M.Sc.) starts in the winter semester 2018

On April 4, 2018, Posted by , In News, By , With Comments Off on Remote Learning: new Master in Biotechnology (M.Sc.) starts in the winter semester 2018

Esslingen University of Applied Sciences together with the scientific publisher Springer, established a new remote learning Master in Biotechnology. This Master is the perfect solution for professionals who want to continue their education, without leaving their job. After 5,5 semesters, the students will receive a Master of Science (M.Sc.) in…

HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

On April 4, 2018, Posted by , In News, By ,, , With Comments Off on HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

Two awards at once, both carrying high monetary prizes, go to young researchers from the Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ): Simon Raffel will receive the 2018 Walter Schulz Prize for his discovery how misregulated breakdown of amino acids…

EMBL: microglia nibbling on brain synapses (captured on film)

On March 27, 2018, Posted by , In Research Article, By ,, , With Comments Off on EMBL: microglia nibbling on brain synapses (captured on film)

For the first time, EMBL researchers have captured microglia nibbling on brain synapses. Their findings show that the special glial cells help synapses grow and rearrange, demonstrating the essential role of microglia in brain development. Nature Communications publishes the results on March 26. Multiple synapse heads send out filopodia (green)…

Heidelberg, Paris, Prague and Warsaw Build European University Alliance

On March 22, 2018, Posted by , In News, By , , With Comments Off on Heidelberg, Paris, Prague and Warsaw Build European University Alliance

Signing of the declaration on the founding of the European University Alliance “4EU“: From left to right, Prof. Dr Marcin Palys (University of Warsaw), Prof. Dr Jean Chambaz (Sorbonne University), Prof. Dr Bernhard Eitel (Heidelberg University) and Vice-President Prof. Dr Lenka Rovná (on behalf of the President of Charles University…

Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death of advanced squamous lung cancer

On March 21, 2018, Posted by , In News, By , , With Comments Off on Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death of advanced squamous lung cancer

Phase III IMpower131 study showed Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met…

HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

On March 21, 2018, Posted by , In News, By , , With Comments Off on HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine at the German Cancer Research Center (DKFZ), is looking back on ten successful years. In numerous types of cancer, HI-STEM researchers have been able to show the role of stem cells in the development, spread and therapy resistance of…

EMBL: From blood vessels to blood stem cells

On March 21, 2018, Posted by , In Research Article, By , , With Comments Off on EMBL: From blood vessels to blood stem cells

EMBL scientists discover how blood vessel cells become blood stem cells during embryonic development Cells – like those that make up our skin, heart, and brain – develop from stem cells. However, blood stem cells develop from vascular cells which line the walls of our blood vessels. EMBL Rome group…

Press Release – BioRN Lounge: Dr. Marc Stanke from Accantec talked about “The Data Scientist”

On March 21, 2018, Posted by , In Press Releases, By , With Comments Off on Press Release – BioRN Lounge: Dr. Marc Stanke from Accantec talked about “The Data Scientist”

Heidelberg, 21.03.2018 It has become a common habit in the BioRN cluster for the life science companies as well for scientists from our research institutes, to join the monthly BioRN Lounge. The BioRN Lounge is the prime monthly networking event for BioRN members. It is the occasion for exchange, meeting…